High severity · published Sep 19, 2022
CVE-2022-38351
A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page
8.8
CVSS
1.1%
EPSS
No
On KEV
Description
A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.
CVSS vector
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack vector
Network
Complexity
Low
Privileges
Low
User interaction
None
Confidentiality
High
Integrity
High
Availability
High
Scope
Unchanged
Exploitation
Is it being used?
Exploit prediction (EPSS)1.1% · higher than 66% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
B2
Biostar 2 · Supremainc
2.8.16 · source: NVD
Affected product
B2
Biostar 2
Supremainc
More from Biostar 2
8.8
CVE-2023-33364
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server
8.8
CVE-2023-33366
A SQL injection vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows authenticated users to inject arbitrary SQL directives into an SQL statement and execute…
8.8
CVE-2023-31923
Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions
7.7
CVE-2026-31278
An issue in the /api/v2/setting/adserversetting endpoint of Suprema BioStar 2 before 2.9.12 and and BioStar X before 1.0.2 allows attackers to obtain Active Directory service…
7.5
CVE-2023-33363
An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers